Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.24%, DAX (0.21%), CAC40 +0.22%

Oct 30 ,2026

  • Synopsis

    • European indices are set to open mixed with Asian equities on another downward trajectory to round off a difficult week and month. Very steep declines in South Korea's tech chain although finishing off their lows,

    • BOJ left the policy rate unchanged at 1.25% as widely expected. Vote count was 8-1;

    • Major US equity indices finished mostly lower in Thursday trading. However, breadth was very positive, with equal-weight outperforming the cap-weighted index by ~150 bp.

    • Google under pressure following mostly softer Q3 results. Search a key area of scrutiny as growth slowed to +12% from +17% in Q2,

    • Friday sees, in central banks, Bank of Italy's Panetta speech at World Savings Day. Croatia central bank's Švaljek presentation at 9:00CET on the occasion of World Savings Day at event organized by the Croatian Chamber of Economy. BOE's Mills speech at 9:00GMT at conf co-hosted by Univ. of Exeter and South West Business Council.

    • Economic data due today: Germany Q3 preliminary GDP, Oct preliminary CPI, unemployment rate, France Q3 preliminary GDP, Oct preliminary CPI, Sep consumer goods spending, PPI, Italy Q3 preliminary GDP, Oct preliminary CPI, Spain Q3 preliminary GDP, Oct preliminary CPI, Eurozone Q3 preliminary GDP, Sep unemployment rate, Switzerland Oct leading indicator - KOF, Sep retail sales, UK Oct house price index - Lloyds Bank, Portugal Q3 preliminary GDP, Oct preliminary CPI, Netherlands Q3 preliminary GDP, Sep PPI, Greece Sep unemployment rate, PPI, Belgium Sep PPI, Aug retail sales, Norway Oct retail sales, Denmark Sep unemployment rate, Finland Q3 preliminary GDP, Austria Q3 preliminary GDP, Sep PPI

    • Earnings reported so far today: (GXI.GR) Gerresheimer, Trifork Holding (TRIFOR.DC), Heijmans (HEIJM.NA), (AKTIA.FH) Aktia Bank, (SCOR) SCR.FP, Scatec (SCATCH.NO), (ACA.FP) Credit Agricole, (FUCHS) FPE3.GR, (FUR.NA) Fugro, (SPIE.FP) SPIE, (CAP.FP) Capgemini.

    • Holidays: Sweden (early close for All Saint's Day)

  • Politics/Macro/World News

    • Binance Estimates $6.3B Hacked in Crypto's Biggest Heist (BBG)

    • Pentagon tells Europeans to cool their rhetoric on Russia, sources say (Reuters )

  • Top company news

    • Earnings/updates

      • UMG.NA (Universal Music Group) -- reports Q3 adjusted EBITDA €729.0M vs consensus €691.0M

      • CAP.FP (Capgemini) -- reports Q3 revenue €6.07B vs StreetAccount €5.99B; c.FX growth +11.7% vs StreetAccount +10.3%; Upgrades 2026 financial targets

      • CS.FP (AXA) -- reports 9M Gross written premiums & other revenues €93B vs consensus €92.73B

      • CABK.SM (CaixaBank) -- reports Q3 net income attributable €1.76B vs consensus €1.63B

      • CABK.SM (CaixaBank) -- announces costs remain on track with guidance - slides

      • AMP.IM (Amplifon) -- reports Q3 net income €26.6M vs FactSet €17.8M [6 est, €9.6-27.4M]

      • ETL.FP (Eutelsat Communications) -- reports Q1 revenue €286.0M vs consensus €299.0M; confirm FY26-27 financial objectives

      • SPIE.FP (SPIE) -- reports Q3 revenue €2.89B vs FactSet €2.85B [3 est, €2.82-2.88B]

      • PSM.GR (ProSiebenSat.1 Media) -- updates FY26 guidance

      • EUROB.GA (Eurobank SA) -- reports Q3 adjusted net income €432.6M vs FactSet €413.1M

      • PHM.SM (Pharma Mar) -- reports 9M net income €8.7M vs year-ago €15.3M

      • FPE3.GR (FUCHS SE) -- reports 9M EPS €2.14 vs year-ago €1.73

      • TFI.FP (TF1) -- reports Q3 net income attributable €21M vs consensus €12.9M; 2026 targets maintained, with visibility remaining limited

      • EMEIS.FP (Emeis SA) -- reports Q3 revenue €1.53B, +4% vs year-ago €1.48B

      • FUR.NA (Fugro) -- reports Q3 revenue €525.2M vs FactSet €470.0M [4 est, €445-490M]

      • NK.FP (Imerys) -- reports Q3 net income €43M, +10% vs year-ago €39M

      • PRS.SM (Promotora de Informaciones) -- reports 9M revenue €719M, +18% vs year-ago €609M

      • XFAB.FP (X-FAB Silicon Foundries) -- reports Q3 net income ($2.8M) vs FactSet ($7.0M) [2 est, ($11.9)-(2M)]

      • ECMPA.NA (Eurocommercial Properties) -- reports 9M EPS €2.42 vs year-ago €1.37

      • ADOC.FP (Adocia) -- reports Q3 revenue €0.0M vs year-ago €0.4M; reaffirms cash runway extended to Q1 of 2028

      • MTU.FP (Manitou BF) -- reports Q3 revenue €642M, +13% vs year-ago €568M

      • P86.GR (Paradigm Biopharmaceuticals) -- reports Q1 net cash from / (used in) operating activities (A$13.5M) - Appendix 4C

      • ALMDT.FP (MEDIAN Technologies) -- reports H1 net income (€26.9M) vs year-ago (€9.2M); cash runway through H1 of 2028 with potential to extend into H1 of 2029

      • F3C.GR (SFC Energy) -- raises FY2026 earnings guidance

    • M&A

      • EVK.GR (Evonik Industries) -- Evonik to say no to BASF's €24/share offer - FT

      • VU.FP (VusionGroup) -- Vusion Completes Acquisition of In-Store Media

      • ECMPA.NA (Eurocommercial Properties) -- acquires Les Grands Prés, in Belgium and launches capital raise of 5.2M new shares via an accelerated bookbuild offering

      • 9532.JP (Osaka Gas) -- Enagas completes the acquisition of of an additional 20% stake in Planta de Regasificación de Sagunto (Saggas) from Osaka Gas

      • Pacific National seeking to sell business in one line - The Australian

    • Healthcare

      • BAYN.GR (Bayer AG) -- Missouri jury rules unanimously for Monsanto in Theresa Aretino, et al. v. Monsanto

      • SOBI.SS (Swedish Orphan Biovitrum) -- discloses Chairman David Meek will not seek re-election at 2027 Annual General Meeting in May '27

      • PHM.SM (Pharma Mar) -- resolves to appoint Elena Calleja Crespo as CFO effective 1-Jan-27; to succeed María Luisa de Francia Caballero

      • OSE.FP (OSE Immunotherapeutics) -- reports additional results of Combi-TED Phase 2 trial with Tedopi (OSE2101) in metastatic Non-Small Cell Lung Cancer (NSCLC)

    • Other

      • BT.A.LN (BT Group) -- Virgin Media O2 approaching deal to use BT's broadband network - FT

      • BAER.SW (Julius Baer Group) -- Ltd. will launch its previously announced new share buy-back programme of up to a total value of CHF 600M on 2-Nov-26.

      • FRVIA.FP (Forvia) -- and Raiqon enter strategic AI partnership

      • ELI.BB (Elia Group SA/NV) -- Elia Transmission Belgium publishes the results of three Capacity Remuneration Mechanism (CRM) auctions, covering the 2027-28, 2028-29, and 2030-31 supply periods

      • NTZA.GR (Natuzzi) -- calls special shareholder meeting to approve capital increase and rights issue - 6-K

      • Focus on AI spending, cloud growth in Amazon results later today; AI-link stocks remain lower while Pure Plays see pockets of strength in intraday themes (29-Oct)

      • Rio Tinto confirms occurrence of seismic activity along a rock fault zone at Oyu Tolgoi in Mongolia; reports zero fatalities - company website

      • Underground operations at Oyu Tolgoi temporarily suspended -- Bloomberg

  • Key rating changes

    • Downgrades

      • WCH.GR (Wacker Chemie) -- to sell from hold at Deutsche Bank

      • WCH.GR (Wacker Chemie) -- to hold from buy at Berenberg

  • Data

    • Nikkei (2.44%) to 63082.27

    • Hang Seng +1.60% to 23325.43

    • Shanghai Composite (1.08%) to 3611.96

    • S&P futures (66.0) vs prior close of 7754.3

    • €-$ +0.0001 or +0.01% to 1.1184 $-¥ (0.16) or (0.10%) to 157.55

    • €-¥ (0.16) or (0.09%) to 176.17

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.